As drugmakers await testing to see how well their Covid-19 vaccines work against Omicron, they have begun expressing concern the shots won’t be as effective and there may be a need for modified doses on.wsj.com
@WSJ3 years ago
As drugmakers await testing to see how well their Covid-19 vaccines work against Omicron, they have begun expressing concern the shots won’t be as effective and there may be a need for modified doses on.wsj.com
@WSJ3 years ago
As drugmakers await testing to see how well their Covid-19 vaccines work against Omicron, they have begun expressing concern the shots won’t be as effective and there may be a need for modified doses on.wsj.com
@WSJ4 years ago
Pfizer, Moderna and other seven companies promised not to file for approval of their Covid-19 vaccines until the shots have shown to work safely, as executives say they aren’t cutting corners in testing or manufacturing on.wsj.com
